| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Alpa Laboratories Limited (NSE: ALPA)
ALPA Technical Analysis
3
| As on 25th Apr 2024 ALPA SHARE Price closed @ 96.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 84.43 & Buy for SHORT-TERM with Stoploss of 95.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALPASHARE Price
| Open | 96.05 | Change | Price | % |
| High | 98.00 | 1 Day | 0.80 | 0.84 |
| Low | 95.90 | 1 Week | 6.90 | 7.69 |
| Close | 96.60 | 1 Month | 8.75 | 9.96 |
| Volume | 43798 | 1 Year | 35.90 | 59.14 |
| 52 Week High 85.45 | 52 Week Low 49.30 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| ALPA Daily Charts |
ALPA Intraday Charts |
Whats New @ Bazaartrend |
ALPA Free Analysis |
|
|
ALPA Important Levels Intraday
| RESISTANCE | 100.65 |
| RESISTANCE | 99.35 |
| RESISTANCE | 98.55 |
| RESISTANCE | 97.74 |
| SUPPORT | 95.46 |
| SUPPORT | 94.65 |
| SUPPORT | 93.85 |
| SUPPORT | 92.55 |
ALPA Target April 2024
| 4th UP Target | 139.03 |
| 3rd UP Target | 126.98 |
| 2nd UP Target | 119.53 |
| 1st UP Target | 112.08 |
| 1st DOWN Target | 90.82 |
| 2nd DOWN Target | 83.37 |
| 3rd DOWN Target | 75.92 |
| 4th DOWN Target | 63.87 |
ALPA Weekly Target
| 4th UP Target | 105.69 |
| 3rd UP Target | 101.33 |
| 2nd UP Target | 98.64 |
| 1st UP Target | 95.94 |
| 1st DOWN Target | 88.26 |
| 2nd DOWN Target | 85.56 |
| 3rd DOWN Target | 82.87 |
| 4th DOWN Target | 78.51 |
ALPA Target2024
| 4th UP Target | 222.77 |
| 3rd UP Target | 184.46 |
| 2nd UP Target | 160.77 |
| 1st UP Target | 137.09 |
| 1st DOWN Target | 69.51 |
| 2nd DOWN Target | 45.83 |
| 3rd DOWN Target | 22.14 |
| 4th DOWN Target | -16.17 |
Alpa Laboratories Limited ( NSE INDIA Symbol : ALPA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALPA Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 11.00 | |
| 10 Day Avg Volume | Traded 17.74 % More then 10 Day Average Volume | ||
ALPA Other Details
| Segment | EQ | |
| Market Capital | 1084933248.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
ALPA Address
 |
||
ALPA Latest News
ALPA Business Profile
Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India. Address: 33/2 Pigdamber, Indore, India, 453446
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service